Franklin Genomic Advancements ETF (HELX)

BATS: HELX · IEX Real-Time Price · USD
32.13
0.71 (2.25%)
At close: May 19, 2022 4:00 PM
32.13
0.00 (0.00%)
After-hours:May 19, 2022 8:00 PM EDT
Assets$15.30M
NAV$33.99
Expense Ratio0.50%
PE Ratio21.49
Shares Out450,000
Dividend (ttm)$0.12
Dividend Yield0.37%
Ex-Dividend DateDec 30, 2021
1-Year Return-26.76%
Volume1,293
Open35.55
Previous Close31.42
Day's Range31.11 - 32.23
52-Week Low33.57
52-Week High58.61
Beta1.06
Holdings52
Inception DateFeb 25, 2020

About HELX

Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

Asset ClassEquity
RegionGlobal
IssuerFranklin Templeton
Stock ExchangeBATS
Ticker SymbolHELX
Index TrackedSolactive Genomics Index

Top 10 Holdings

42.98% of assets
NameSymbolWeight
Thermo Fisher ScientificTMO6.57%
RepligenRGEN5.48%
AstraZenecaAZN4.56%
CatalentCTLT4.10%
DanaherDHR4.02%
SAMSUNG BIOLOGICS CO LTD207940.KS3.82%
BrukerBRKR3.82%
Agilent TechnologiesA3.74%
AvantorAVTR3.49%
Regeneron PharmaceuticalsREGN3.38%
View More Holdings

Dividends

Ex-DividendAmountPay Date
Dec 30, 2021$0.00394Jan 7, 2022
Dec 13, 2021$0.11415Dec 21, 2021
Dec 14, 2020$0.05178Dec 23, 2020
Full Dividend History

News

Invest in the Fully Mapped Human Genome With This ETF

Scientists have completed mapping the human genome. New research from the Telomere-to-Telomere (T2T) Consortium, a loose collaborative of about 100 scientists, shows that the team has completed a challe...

1 month ago - ETF Trends